/ISPC
ISPC Stock - iSpecimen Inc.
Healthcare|Medical - Diagnostics & ResearchNASDAQ
$0.37-4.59%
$0.02 (-4.59%) • Dec 19
44
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.48
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.41
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ISPC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.37 – $0.37
TARGET (TP)$0.43
STOP LOSS$0.34
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.80
52W High$3.38
52W Low$0.36
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $9.29M | $9.93M | $10.40M | $11.14M | $8.18M |
| Gross Profit | $3.99M | $5.11M | $5.65M | $5.89M | $4.60M |
| Gross Margin | 42.9% | 51.4% | 54.3% | 52.9% | 56.2% |
| Operating Income | $-12,728,045 | $-11,169,349 | $-10,186,082 | $-5,925,246 | $-2,406,380 |
| Net Income | $-12,497,805 | $-11,099,488 | $-10,245,922 | $-8,961,815 | $-4,652,084 |
| Net Margin | -134.5% | -111.8% | -98.5% | -80.5% | -56.8% |
| EPS | $-17.58 | $-1.23 | $-20.47 | $-24.51 | $-144.38 |
Company Overview
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ISPCBeat Rate
20%
Last 15 quarters
Avg Surprise
-1419.7%
EPS vs Estimate
Beats / Misses
3/12
Last 12 quarters
Latest EPS
$-0.48
Q4 2025
EPS Surprise History
Q1 24
-2733.3%
$-6.80vs$-0.24
Q2 24
-2270.4%
$-6.40vs$-0.27
Q3 24
-1257.1%
$-3.80vs$-0.28
Q4 24
+44.7%
$-2.10vs$-3.80
Q1 25
No data
Q2 25
-57.0%
$-6.28vs$-4.00
Q3 25
+88.9%
$-0.42vs$-3.80
Q4 25
+87.4%
$-0.48vs$-3.80
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 17, 2025 | $-3.80 | $-0.48 | +87.4% | ✓ BEAT |
Q3 2025 | Aug 14, 2025 | $-3.80 | $-0.42 | +88.9% | ✓ BEAT |
Q2 2025 | Apr 14, 2025 | $-4.00 | $-6.28 | -57.0% | ✗ MISS |
Q1 2025 | Mar 12, 2025 | — | $-6.80 | — | — |
Q4 2024 | Nov 7, 2024 | $-3.80 | $-2.10 | +44.7% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $-0.28 | $-3.80 | -1257.1% | ✗ MISS |
Q2 2024 | May 7, 2024 | $-0.27 | $-6.40 | -2270.4% | ✗ MISS |
Q1 2024 | Mar 13, 2024 | $-0.24 | $-6.80 | -2733.3% | ✗ MISS |
Q4 2023 | Nov 2, 2023 | $-0.35 | $-4.60 | -1214.3% | ✗ MISS |
Q3 2023 | Aug 2, 2023 | $-0.30 | $-7.80 | -2500.0% | ✗ MISS |
Q2 2023 | May 4, 2023 | $-0.32 | $-5.40 | -1587.5% | ✗ MISS |
Q1 2023 | Mar 14, 2023 | $0.37 | $-4.80 | -1397.3% | ✗ MISS |
Q4 2022 | Nov 8, 2022 | $-0.34 | $-7.00 | -1958.8% | ✗ MISS |
Q3 2022 | Aug 4, 2022 | $-0.27 | $-6.00 | -2122.2% | ✗ MISS |
Q2 2022 | May 10, 2022 | $-0.25 | $-5.40 | -2060.0% | ✗ MISS |
Q1 2022 | Feb 17, 2022 | $-0.22 | $-5.41 | -2359.3% | ✗ MISS |
Q4 2021 | Nov 4, 2021 | — | $-4.40 | — | — |
Q3 2021 | Aug 10, 2021 | — | $-17.40 | — | — |
Q2 2021 | Jun 18, 2021 | — | $-34.04 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-84.67 | — | — |
Latest News
iSpecimen Appoints Katharyn Field As CEO, Secretary, And Treasurer Following Robert Lim's Resignation
➖ NeutralBenzinga•Nov 7, 2025, 09:41 PM
iSspecimen Files For Mixed Shelf Of Up To $100M
➖ NeutralBenzinga•Oct 23, 2025, 09:08 PM
iSpecimen Shares Halted On Circuit Breaker To The Upside, Stock Now Up 248.01%
📈 PositiveBenzinga•Sep 9, 2025, 03:27 PM
iSpecimen Shares Halted On Circuit Breaker To The Upside, Stock Now Up 150.30%
📈 PositiveBenzinga•Sep 9, 2025, 03:11 PM
iSpecimen shares are trading higher after the company announced it advanced its $200 million Solana-based digital asset strategy.
📈 PositiveBenzinga•Sep 5, 2025, 12:46 PM
iSpecimen shares are trading higher after the company announced it advanced its $200 million Solana-based digital asset strategy.
📈 PositiveBenzinga•Sep 4, 2025, 08:33 PM
iSpecimen Advances $200M Solana-Based Digital Asset Strategy, Explores Tokenized Real-World Asset Opportunities
📈 PositiveBenzinga•Sep 4, 2025, 08:09 PM
ISPC stock has given up its prior gain. iSpecimen shares were trading higher after the company announced it has upgraded its marketplace infrastructure as part of its first completed milestone in its digital transformation with Salesstack.
➖ NeutralBenzinga•Aug 21, 2025, 03:38 PM
iSpecimen shares are trading higher after the company announced it has upgraded its marketplace infrastructure as part of its first completed milestone in its digital transformation with Salesstack.
📈 PositiveBenzinga•Aug 21, 2025, 12:25 PM
iSpecimen Completes First Milestone In Digital Transformation With Salestack, Upgrades Marketplace Infrastructure
📈 PositiveBenzinga•Aug 21, 2025, 12:10 PM
Frequently Asked Questions about ISPC
What is ISPC's current stock price?
iSpecimen Inc. (ISPC) is currently trading at $0.37 per share. The stock has moved -4.59% today.
What is the analyst price target for ISPC?
No analyst price targets are currently available for this stock.
What sector is iSpecimen Inc. in?
iSpecimen Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.
What is ISPC's market cap?
iSpecimen Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ISPC pay dividends?
No, iSpecimen Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBIAF
bioAffinity Technologies, Inc.
$1.24
Mkt Cap: $0.0B
BIVI
BioVie Inc.
$1.41
Mkt Cap: $0.0B
BJDX
Bluejay Diagnostics, Inc.
$0.80
Mkt Cap: $0.0B
GLMD
Galmed Pharmaceuticals Ltd.
$0.85
Mkt Cap: $0.0B
HSCS
HeartSciences Inc.
$2.36
Mkt Cap: $0.0B
NDRA
ENDRA Life Sciences Inc.
$5.16
Mkt Cap: $0.0B
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$1.72
Mkt Cap: $0.0B
TOVX
Theriva Biologics, Inc.
$0.19
Mkt Cap: $0.0B
VTAK
Catheter Precision, Inc.
$1.98
Mkt Cap: $0.0B
ZCMD
Zhongchao Inc.
$0.60
Mkt Cap: $0.0B
Explore stocks similar to ISPC for comparison